Log in to save to my catalogue

Influence of [ 18 F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients-A PET/CT R...

Influence of [ 18 F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients-A PET/CT R...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f68fc02bb2c24c48829d86cb16fff365

Influence of [ 18 F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients-A PET/CT Registry Study

About this item

Full title

Influence of [ 18 F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients-A PET/CT Registry Study

Publisher

Switzerland: MDPI AG

Journal title

Diagnostics (Basel), 2023-07, Vol.13 (14), p.2420

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

There is a lack of evidence regarding the clinical impact of [
F]fluorodeoxyglucose positron emission tomography/computed tomography ([
F]FDG-PET/CT, hereinafter referred to as PET/CT), especially regarding management changes and their link to overall survival. We analyzed 52 PET/CTs in 47 stage I-IV breast cancer patients, selected from a pr...

Alternative Titles

Full title

Influence of [ 18 F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients-A PET/CT Registry Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f68fc02bb2c24c48829d86cb16fff365

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f68fc02bb2c24c48829d86cb16fff365

Other Identifiers

ISSN

2075-4418

E-ISSN

2075-4418

DOI

10.3390/diagnostics13142420

How to access this item